ArticleArthritis research & therapy2016

Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.

Andreas Keil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.